... Capivasertib (AZD-5363) at 2021 San Antonio Breast Cancer Symposium. ... 2021--(BUSINESS WIRE)--SynDevRx, Inc., a clinical-stage biotechnology ...
News
- SynDevRx To Present Pre-Clinical Combination Data of Evexomostat (SDX-7320) with ...
- Datopotamab deruxtecan continues to show promise in breast cancer - The Pharma Letter
These data were featured during an oral presentation (GS1-05) at the 2021 San Antonio Breast Cancer Symposium. Daiichi Sankyo's shares closed up ...
- Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast ... - BioSpace
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021 - read this article along with other careers ...
- Genomic-Based Targeted Therapy Improved PFS for Certain Metastatic Breast Cancers ...
The following article features coverage from the 2021 San Antonio ... Some study authors declared affiliations with biotech, pharmaceutical, ...
- The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain ... - Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. ... San Antonio Breast Cancer Symposium Presentations.